back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2018-09-19 Tx date 2018-09-17 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
$30,000
+200,000 vol $0.15 each |
135,000 | |
| Filed 2018-09-19 Tx date 2018-09-17 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-30,000
-200,000 vol $0.15 each |
-65,000 | |
| Filed 2018-06-27 Tx date 2018-06-26 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
|
Common Shares
46 - Compensation for services
|
$545,376
+4,277,465 vol $0.1275 each |
14,570,776 | |
| Filed 2018-06-27 Tx date 2018-06-26 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
|
Common Shares
46 - Compensation for services
|
$146,200
+1,000,000 vol $0.1462 each |
10,293,311 | |
| Filed 2018-06-21 Tx date 2018-06-19 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$-170,000
-1,000,000 vol $0.17 each |
9,293,311 | |
| Filed 2018-06-21 Tx date 2018-06-19 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
|
Common Shares
47 - Acquisition or disposition by gift
|
-1,500,000 vol |
||
| Filed 2018-06-21 Tx date 2018-06-19 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
|
Common Shares
47 - Acquisition or disposition by gift
|
-500,000 vol |
10,293,311 | |
| Filed 2018-06-19 Tx date 2018-06-19 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
|
Common Shares
47 - Acquisition or disposition by gift
|
-1,500,000 vol |
9,293,311 | |
| Filed 2018-03-15 Tx date 2018-03-12 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
|
Common Shares
46 - Compensation for services
|
$810,000
+3,000,000 vol $0.27 each |
10,793,311 | |
| Filed 2018-02-14 Tx date 2018-02-13 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
$1,181,250
+4,500,000 vol $0.2625 each |
5,587,488 | |
| Filed 2018-01-17 Tx date 2018-01-16 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
|
Common Shares
46 - Compensation for services
|
$122,743
+762,379 vol $0.161 each |
7,793,311 | |
| Filed 2017-12-20 Tx date 2017-12-18 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
|
Common Shares
46 - Compensation for services
|
$15,749
+36,627 vol $0.43 each |
7,030,932 | |
| Filed 2017-12-19 Tx date 2017-12-18 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
-200,000 vol |
135,000 | |
| Filed 2017-12-19 Tx date 2017-12-18 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
+200,000 vol |
335,000 | |
| Filed 2017-12-13 Tx date 2017-12-12 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-30,360
-66,000 vol $0.46 each |
1,087,488 | |
| Filed 2017-12-06 Tx date 2017-12-06 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
|
Common Shares
47 - Acquisition or disposition by gift
|
-1,046,667 vol |
6,994,305 | |
| Filed 2017-10-31 Tx date 2017-10-30 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
|
Common Shares
46 - Compensation for services
|
$13,745
+99,099 vol $0.1387 each |
8,040,972 | |
| Filed 2017-09-12 Tx date 2017-09-11 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
|
Common Shares
46 - Compensation for services
|
$14,499
+100,000 vol $0.145 each |
7,893,598 | |
| Filed 2017-09-12 Tx date 2017-09-11 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
|
Common Shares
46 - Compensation for services
|
$5,247
+48,275 vol $0.1087 each |
7,941,873 | |
| Filed 2017-09-12 Tx date 2017-09-11 |
$ATT
Abattis Bioceuticals Corp. |
David, Rene
5 - Senior Officer of Issuer
Holder: Crimson Opportunities Ltd. (Indirect Ownership)
|
Options
50 - Grant of options
|
$145,000
+1,000,000 vol $0.145 each |
2,885,000 |